Parenteral Anticoagulants

This publication has 177 references indexed in Scilit:

• Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra®) on human osteoblasts in vitro
  British Journal of Surgery, 2005
• Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies
  American Heart Journal, 2003
• ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)
  Published by Elsevier ,2000
• Nitroglycerin-induced heparin resistance
  American Heart Journal, 1991
• Intravenous nitroglycerin-induced heparin resistance: A qualitative antithrombin III abnormality
  American Heart Journal, 1990
• The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg
  The Journal of Clinical Pharmacology, 1988
• HEPARIN DOSES AND MAJOR BLEEDINGS
  The Lancet, 1986
• Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
  Biochemical and Biophysical Research Communications, 1983
• The separation of active and inactive forms of heparin
  Biochemical and Biophysical Research Communications, 1976
• Heparin Metabolism: Isolation and Characterization of Uroheparin
  Nature, 1966